SPL Medical is a young medical research and development company that has already successfully developed new technologies in the field of MRI contrast agents. SPL Medical's first project turns the diagnostic world upside-down: Ferrotran®. This innovative Gadolinium-free contrast agent is more reliable in the early detection of metastases in prostate cancer than any product currently available on the market and also offers the highest potential for other indications.
Abonnieren Sie unseren Newsletter und bleiben Sie in Sachen SPL-Medical und Ferrotran® auf dem Laufendem.